Filing Details
- Accession Number:
- 0000899140-25-000479
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-28 16:51:41
- Reporting Period:
- 2025-03-26
- Filing Date:
- 2025-03-28
- Accepted Time:
- 2025-03-28 16:51:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1808898 | Benitec Biopharma Inc. | BNTC | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1569064 | Suvretta Capital Management, Llc | 540 Madison Avenue 7Th Floor New York NY 10022 | No | No | No | No | |
1869640 | Aaron Cowen | C/O Suvretta Capital Management, Llc 540 Madison Avenue, 7Th Floor New York NY 10022 | No | No | No | No | |
1939329 | Averill Master Fund, Ltd. | C/O Suvretta Capital Management, Llc 540 Madison Avenue, 7Th Floor New York NY 10022 | No | No | No | No | |
2021243 | Averill Madison Master Fund, Ltd. | C/O Suvretta Capital Management, Llc 540 Madison Avenue, 7Th Floor New York NY 10022 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2025-03-26 | 793,800 | $13.00 | 8,793,245 | No | 4 | P | Indirect | See footnotes |
Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2025-03-26 | 106,200 | $13.00 | 1,066,764 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
Footnotes
- Notes are included on Exhibit 99.1.
- Notes are included on Exhibit 99.1.
- Notes are included on Exhibit 99.1.